Christine Gebski, See Remarks at REPLIGEN CORP (RGEN), sold 6,714 shares at $243.01 ($1.6M) on 2022-08-04, disclosed to the SEC on 2022-08-05.
Open-market sale of $1.6M RGEN by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $243.01 | 3,357 | $816K | 50.0% |
| 2 | $243.01 | 3,357 | $816K | 50.0% |
| Total | $243.01 avg | 6,714 | $1.6M | 100% |
| Filing → |
| RGEN | SELL | 2021-05-18 | $153K | — | Filing → |
| RGEN | SELL | 2021-03-18 | $276K | — | Filing → |